Warren Lammert, Chairman and Co-Founder of The Epilepsy Therapy Project, was honored by Finding a Cure for Epilepsy and Seizures (FACES) on Monday, March 5, 2007 at their Annual Gala in New York City. FACES is a non profit organization affiliated with New York University Medical Center and its Comprehensive Epilepsy Center, under the direction of Orrin Devinsky, MD. Its mission is to improve the quality of life for all people affected by epilepsy through research, education, and community-building events ( ). The FACES Gala is an annual fund raising event enabling the group to further provide care and treatment for children and adults with epilepsy.

The Program note stated:

NYU faces 2007 pays tribute to Warren Lammert for his extraordinary personal generosity in supporting epilepsy treatment and research. Mr. Lammert works closely with the team at NYU faces, where he sits on the Board of Directors, in support of its ongoing mission to better understand, treat and ultimately prevent epilepsy.

The special guest speaker was Tiki Barber, who retired as the New York Giant's all-time leading running back in 2006 and is now a news and sports broadcaster.

We present here both Dr.Devinsky's introductory remarks and Warren Lammert's talk.

Orrin Devinsky, MDOrrin Devinsky, MD

Professor of Neurology, Neurosurgery, and Psychiatry at NYU School of Medicine, Director of the NYU Comprehensive Epilepsy Center

Thank you. Thank you all so much for being here tonight. It is humbling to look out on this sea of support, the incredible people that come together tonight and throughout the year. This has been an amazing year for the FACES family. Five years ago, we spoke here, about a dream – the Epilepsy Phenome Genome Project (EPGP). We envisioned a large collaborative national effort with very ambitious goals. With FACES support, we recruited Ruben Kuzniecky to direct epilepsy research at NYU. Ruben, together with Dan Lowenstein at UCSF, and $400K of FACES support, brought 14 centers through a long planning phase. NIH now funds only the top 8% of research grant applications.

Ambitious projects with big price tags have even slimmer chances. The EPGP ranked in the top 4% and was recently funded for $21M, the largest NIH grant for epilepsy. It is a national repository for information, answers, and hopefully the seed for new therapies.